+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Efficacy and safety of zopiclone and triazolam in the treatment of geriatric insomniacs



Efficacy and safety of zopiclone and triazolam in the treatment of geriatric insomniacs



International Clinical Psychopharmacology 5(Suppl. 2): 39-46



Most studies with zopiclone, a cyclopyrrolone derivative with a short elimination half life (5 h) have compared its hypnotic activity with that of long elimination half life molecules. In this double-blind study in geriatric patients, drugs were administered during 3 weeks and the therapeutic effects of zopiclone at optimal dosage (5 or 7.5 mg) were compared to those of triazolam (0.125 or 0.25 mg). After a 3 day single-blind washout period, placebo responders were excluded and 48 patients were thereafter treated with either placebo (Tétreault et al., 1965), zopiclone or triazolam (Pegram et al., 1980). The initial dosage was increased when indicated at the end of the first week and kept constant thereafter. At the end of the third week of double-blind treatment, a 4 day single-blind placebo washout was performed to assess drug withdrawal effects. Results confirmed the safety and efficacy of both drugs over placebo during active administration. Hypnotic activity was maximal at 7.5 mg of zopiclone and 0.25 mg of triazolam. Drug efficacy was found constant over the 3 week administration both for triazolam and zopiclone. During withdrawal, no true rebound effect was demonstrated but the active drugs were significantly worse than placebo during the first day for sleep onset duration, sleep soundness and quality of sleep. With triazolam some effects persisted up to the third day of withdrawal.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 039988972

Download citation: RISBibTeXText

PMID: 2201729


Related references

Comparative efficacy and safety of triazolam and zopiclone in insomniacs seen in general practice. Current Therapeutic Research 46(6): 1236-1244, 1989

The efficacy of triazolam and chloral hydrate in geriatric insomniacs. Journal of International Medical Research 8(5): 361-367, 1980

A comparison of the efficacy, safety and withdrawal effects of zopiclone and triazolam in the treatment of insomnia. International Clinical Psychopharmacology 5(Suppl. 2): 29-37, 1990

Zopiclone versus triazolam in insomniac geriatric patients: a specific increase in delta sleep with zopiclone. International Clinical Psychopharmacology 5(Suppl. 2): 47-55, 1990

Zopiclone compared with triazolam in insomnia in geriatric patients. Current Therapeutic Research 40(6): 1062-1068, 1986

Efficacy of a reduced triazolam dose in elderly insomniacs. Neurobiology of Aging 6(4): 293-296, 1985

Comparative efficacy of triazolam, flurazepam and placebo in out-patients insomniacs. Journal of International Medical Research 6(4): 337-342, 1978

Zopiclone to geriatric patients. A parallel double-blind dose-response clinical trial of zopiclone as a hypnotic to geriatric patients - a study in a geriatric hospital. Pharmacology 27(Suppl. 2): 173-178, 1983

Zopiclone in the treatment of insomniacs of family practice. Psychiatric Journal of the University of Ottawa 10(3): 165-168, 1985

Long-term treatment of brotizolam and zopiclone in elderly insomniacs. Kawasaki Medical Journal 26(1): 9-11, 2000

Efficacy and safety of zopiclone in the treatment of insomnia. Current Therapeutic Research 42(4): 665-670, 1987

Efficacy and safety of a one-month treatment with zolpidem in middle-aged and elderly insomniacs. Acta Therapeutica 23(1-2): 5-19, 1997

A comparison of zopiclone and propiomazine as hypnotics in outpatients: a multicentre, double-blind, randomized, parallel-group comparison of zopiclone and propiomazine in insomniacs. Current Medical Research and Opinion 13(10): 565-572, 1997

Zopiclone and triazolam in insomnia associated with generalized anxiety disorder: a placebo-controlled evaluation of efficacy and daytime anxiety. International Clinical Psychopharmacology 5(3): 173-183, 1990

Efficacy and tolerance of zopiclone in insomniac geriatric patients. Pharmacology 27(Suppl. 2): 179-187, 1983